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Circular RNAs (circRNAs) are a novel type of endogenous noncoding RNA receiving
increasing attention. They have been shown to act as a natural microRNA sponges that
repress the activity of corresponding miRNAs by binding with them, thus regulating target
genes. Numerous studies have shown that miRNAs are involved in the pathogenesis of
neurological diseases. Therefore, circRNAs may act as important regulatory factors in
the occurrence and development processes of neurological disease.
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Differences between species are embodied in both gene numbers and the regulation of gene
expression. Recent studies have demonstrated that non-coding RNAs play an important role in
regulating gene expression. CircRNAwas first discovered as a novel type of endogenous non-coding
RNAs in the 1970s (Sanger et al., 1976; Arnberg et al., 1980; Cocquerelle et al., 1993), however,
the function of these special structures has only recently been revealed and appreciated. In this
review, we will highlight recent studies of the latest progress in the circRNAs field, in the context of
neurological diseases.
CircRNA STRUCTURE
CircRNAs are a novel type of endogenous noncoding RNA, different from the linear RNAs,
which form closed loop structures with a covalent bond linking the 3′ and 5′ ends. Consequently,
they do not possess polyadenylated tails (Jeck et al., 2013; Chen et al., 2015). Classic RNA
detection methods can only separate RNA molecules with polyadenylated tails, so circRNAs were
ignored in previous studies. Since the development of high-throughput sequencing techniques
and bioinformatics analysis programs, researchers have discovered thousands of circRNAs in
mammalian cells (Salzman et al., 2012; Memczak et al., 2013). CircRNAs are abundant in
plasma, sometimes at levels 10-folds higher than the corresponding linear mRNAs, due to their
increased stability. Nuclease hydrolyzes can recognize the tails of linear RNAs, while circular
RNAs form covalently closed loop structures that protect them. As a result, circular RNAs
are not susceptible to degradation by RNA exonuclease or RNase (Salzman et al., 2012; Jeck
et al., 2013; Memczak et al., 2013). CircRNAs are highly enriched in eukaryotic organisms and
display elevated sequence conservation with specific expression in various tissues during different
developmental stages. CircRNAs mainly arise from the exons of protein-coding genes and can
also be derived from intronic areas, untranslated regions (UTRs), intergenic loci and antisense
sequences of known transcripts (Jeck et al., 2013; Memczak et al., 2013). CircRNA biogenesis
remains unclear, several models were proposed to explain the possible formation of ecircRNAs:
Lariat, Intron-pairing, and resplicing-driven circularization (Figure 1; Chen et al., 2015). Some
circRNAs may have miRNA response elements (MREs) and can interact with miRNAs (Hansen
et al., 2011).
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FIGURE 1 | Possible models and function of circRNA biogenesis. (A) Lariat-driven circularization, (B) Intron-pairing-driven circularization, (C) Resplicing-driven
circularization, and (D) Function as miRNAs sponge.
CircRNA FUNCTION
Due to their high expression level and stability, circRNAs can
act as competitive endogenous RNAs (ceRNAs). CeRNAs contain
sharedMREs and can compete formiRNAbinding. Furthermore,
circRNAs have the same selective capture of transcribed
sequences with corresponding linear mRNAs, which may
perform specific functions through influencing the combination
of other RNAs. CircRNAs play an important role in the micro-
adjustment of miRNA expression levels. CircRNAs can perturb
miRNA function by competing with miRNA combination, thus
preventing miRNA’s effect on the posttranslational repression of
target-coding RNA species, and then regulating the expression
levels of target genes (Hansen et al., 2013a; Rybak-Wolf et al.,
2015). Studies have revealed that the ability of circRNAs to
combine with miRNAs is 10 times higher than other known
transcriptions (Chen et al., 2015). A circRNA antisense to the
cerebellar degeneration-related protein 1 transcript (CDR1as)
can harbor more than 70 miR-7 binding sites and cannot be
degraded by RNA-induced silencing complexes (RISCs) (Hansen
et al., 2013a). Acting as a natural miRNA sponge, CDR1as can
negatively regulate miR-7 (Salmena et al., 2011; Danan et al.,
2012; Memczak et al., 2013). Therefore, CDR1as is also called
the circular RNA sponge for miR-7 (CiRS-7). High CDR1as
expression can decrease miR-7 activity by binding to it and
thus increasing target gene expression; therefore, low CDR1as
expression decreases miR-7 target gene expression. Moreover,
CDR1as seems to be degraded by miR-671 but not miR-
7 (Hansen et al., 2011, 2013a; Memczak et al., 2013). This
indicates that circRNAs can transport miRNAs. CDR1as may
first combine with miR-7 and transport it to specific sites, where
miR-671 can degrade it and release miR-7. This characteristic is
bound to affect ceRNA function because the combination and
release of multiple miRNAs by circRNAs can affect hundreds
of transcripts (Taulli et al., 2013). Studies have demonstrated
that circRNA from sex-determining region Y (sry) harbors 16
miR-138 binding sites and can act as natural miRNA sponges
to repress miR-138 activity (Hansen et al., 2013a). There are
several other possible circRNA functions. First, they can regulate
the expression of other RNAs through partial base pairing.
For instance, CDR1as can bind with CDR1 mRNA based on
complementary base pairing, thus increasing CDR1 mRNA
stability (Hansen et al., 2011). Second, circRNA can combine with
proteins and regulate their activity or recruit the components
of multiprotein complexes (Bohjanen et al., 1996; Hansen et al.,
2013a; Hentze and Preiss, 2013; Memczak et al., 2013). For
example, CDR1as can bind with Argonaute (AGO) protein.
Finally, circRNAs can act as translation templates to encode
proteins (Chen and Sarnow, 1995; Perriman and Ares, 1998).
CircRNAs may play significant roles in nervous system. Studies
have found that CircRNAs are highly abundant in central nervous
system and are differentially expressed in the brain. circRNAs are
highly enriched in synapses and the expression level of circRNAs
are differentially during neuronal differentiation (Rybak-Wolf
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et al., 2015). The above characteristics suggest that circRNAs
may participate in development of nervous system, especially in
synapse development and plasticity.
CircRNA IN NEUROLOGICAL DISEASE
Recent investigations have suggested that circRNAs may play
crucial roles in the occurrence and development of neurological
diseases and therefore have potential as novel biomarkers
(Table 1). At present, few studies have directly assessed
the functions and mechanisms of circRNAs in neurological
diseases; rather, most are only related to circRNAs functions as
miRNA regulators. One publication reported that circRNAs are
extraordinarily enriched in the brain, especially in neuropils and
dendrites, and may participate in regulating synaptic function
and neural plasticity (You et al., 2015). These characteristics
suggest that circRNAs could play important roles in nervous
system diseases such as epilepsy, Parkinson’s disease (PD), and
Alzheimer’s disease (AD). CDR1as overexpression in zebrafish
embryos decreased midbrain size, which is the same effect
observed following miR-7 silencing (Memczak et al., 2013). A
large number of studies have demonstrated that miR-7 influences
different signaling pathways by acting on other regulatory
factors such as epidermal growth factor receptor (EGFR),
insulin receptor substrate-1 (IRS-1), IRS-2, p21-activated kinase-
1 (Pak1), and Raf1 (Reddy et al., 2008; Webster et al., 2009).
Therefore, CDR1as may be an important regulatory factor in the
pathogenesis and progression of neurological diseases.
CircRNA AND AD
Functional deficiency of CDR1as can upregulate miR-7
expression and may lead to the downregulation of AD-relevant
targets, such as ubiquitin protein ligase A (UBE2A; Bingol
and Sheng, 2011; Lonskaya et al., 2013; Lukiw, 2013). This
autophagic protein is important for clearing amyloid peptides
and is depleted in the AD brain (Lonskaya et al., 2013). This
suggests that CDR1as may participate in AD pathogenesis. In
addition, circRNA from sry can act as a natural miRNA sponge
to repress miR-138 activity (Hansen et al., 2013a). Some studies
have shown miR-138 influences learning and memory abilities
by regulating acyl protein thioesterase 1 (APT1; Tatro et al., 2013;
Schröder et al., 2014).
CircRNA AND PD
As mentioned previously, CDR1as is a negative regulator of miR-
7 (Salmena et al., 2011; Danan et al., 2012; Memczak et al., 2013).
Investigations have revealed that miR-7 can downregulate the
expression of α-synuclein, which is the main component of Lewy
bodies in the PD brain. High neuronal expression of α-synuclein
protein is highly implicated in PD pathogenesis. Moreover, miR-
7-induced α-synuclein downregulation can also protect cells
against oxidative stress (Junn et al., 2009). miRNA-7 can also
protect against 1-methyl-4-phenylpyridinium-induced cell death
by targeting the nuclear factor (NF)-κB signaling pathway (Choi
et al., 2014).
CircRNA AND CEREBROVASCULAR
DISEASE
Circular antisense non-coding RNA in the INK4 locus (cANRIL)
is an antisense transcript from the cyclin-dependent kinase 4
inhibitor (CDK4a, also called INK4a) alternative reading frame
locus (Salzman et al., 2013). Single nucleotide polymorphisms
(SNPs) near INK4/ARF are associated with atherosclerotic
vascular disease. The cANRIL locus is within the SNPs and
the nearest coding gene, and cANRIL can influence INK4/ARF
expression and increase the risk of ASVD (Burd et al., 2010).
TABLE 1 | Functional mechanism of Circular RNAs in neurological disease.
Neurological disease Circular RNA Targets Mechanisms
AD CDR1as miR-7 miR-7 can down-regulate AD-relevant targets, such as UBE2A, which play an important role in the
clearance of amyloid peptides in AD (Bingol and Sheng, 2011; Lukiw, 2013)
Sry miR-138 miR-138 participate in learning and memory ability by regulating APT1 (Hansen et al., 2013a)
PD CDR1as miR-7 miR-7 can downregulate α-synuclein expression and protect cells against oxidative stress (Junn
et al., 2009)
Cerebrovascular disease cANRIL INK4a cANRIL can influence INK4/ARF expression and increase the risk of ASVD (Salzman et al., 2013)
Inflammatory neuropathy hsa-circRNA 2149 Specific expression in leukocytes
CircRNA100783 CircRNA100783 may be involved in chronic CD28-associated CD8(+)T cell aging (Wang et al., 2015)
Sry miR-138 miR-138 can balance the expression between Th1 and Th2 through suppressing the function of
RUNX3 (Fu et al., 2015)
Nervous System Neoplasms CDR1as miR-7 miR-7 can repress the expression of EGFR, IRS-1 and IRS-2 thus reduce the active and aggressive
of glioblastoma (Liu et al., 2014)
Prion disease CDR1as PrPC can up-regulate expression of CDR1as (Satoh and Yamamura, 2004; Satoh et al., 2009)
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This observation indicates that circRNA may be involved in the
development of atherosclerotic cerebrovascular disease.
CircRNA AND INFLAMMATORY
NEUROPATHY
Some circRNAs seem to have virus miRNA binding sites and
therefore can affect immune responses. For example, hsa-
circRNA 2149 contains 13 unique, head-to-tail spanning reads.
Researchers detected hsa-circRNA 2149 in CD19+ leukocytes
but not CD341 leukocytes, neutrophils, or HEK293 cells.
Besides, circular RNA100783 may be involved in chronic CD28-
associated CD8(+)T cell aging and could therefore be a novel
biomarker for this conditions (Wang et al., 2015). CircRNA from
sry can repress miR-138 activity. Studies found that miR-138
could balance T helper 1 (Th1) and T helper 2 (Th2) expressions
through suppressing the function of runt-related transcription
factor 3 (RUNX3; Fu et al., 2015). The above studies suggest that
circRNA may participate in inflammatory reactions that induce
neuropathy.
CircRNA AND NERVOUS SYSTEM
NEOPLASMS
Several circRNAs play critical roles in cancer related biological
processes and are dysregulated in cancer tissues (Li et al.,
2015a,b; Qin et al., 2016). CDR1as was first found in brain
tissue and is widely expressed in the nervous system, especially
the cerebrum. Expression analyses of various tumor cell lines
showed widespread expression of CDR1as in neuroblastomas
and astrocytoma (Dropcho et al., 1987; Chen et al., 1990;
Hansen et al., 2013b). Researchers measured miRNA expressions
in different tumor cell lines and found that compared to
normal brain tissue, miR-7 was down-regulated in astrocytoma
and neuroblastoma, Research on a glioblastoma cell line
demonstrated that miR-7 could repress EGFR expression and
also downregulate IRS-1 and IRS-2 expression by suppressing
the activity of protein kinase B (PKB; Liu et al., 2014).
CDR1as acts as negative regulator of miR-7 (Hansen et al.,
2013a). These lines of evidence indicate that circRNAs may be
involved in the pathogenesis and progression of nervous system
neoplasms.
CircRNA AND PRION DISEASES
Prion diseases are devastating neurodegenerative disorders
including Creutzfeldt–Jakob disease (CJD), kuru, Gerstmann-
Straussler syndrome, and fatal familial insomnia (FFI; Prusiner,
1998). Most prion diseases are infectious via transmissible
particles composed of scrapie prion protein (PrPSc), an isomer
of cellular prion protein (PrPC). Studies have revealed that
CDR1as expression is induced by PrPC overexpression (Satoh
and Yamamura, 2004; Satoh et al., 2009). Therefore, CDR1as may
be involved in the prion disease pathogenesis.
CONCLUSIONS
CircRNA function and their relationships with neurological
diseases remain to be fully elucidated, and some problems
remainto be solved. Due to the abundance and stability
of circRNAs in vivo, they may be useful clinical diagnosis
biomarkers in the future. Meanwhile, the regulatory effects of
circRNAs on genes may be considered as treatment targets. In
addition, the ability of circRNAs to act as sponges of related
miRNAs can be exploited as a novel technology to achieve gene
regulation, different cytotypes could differentially be regulated
with a selective silencing approach. Further study on circRNA
structure and function will improve our understanding regarding
neurological disease pathogenesis and lead to new diagnostic and
treatment methods.
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